Table 2.
Pre-erythrocytic antigens used in vaccines.
| Antigen | Vaccine | References | |||||
|---|---|---|---|---|---|---|---|
| Name | Symbol | Size (aa) | Accession* | Expression | Name | Phase | |
| Circumsporozoite protein | CSP | 397 | PF3D7_0304600 | Sporozoite and liver-stage | RTS,S/ASO1 | Phase III | (3, 54) |
| Thrombospondin-related anonymous protein | TRAP | 574 | PF3D7_1335900 | Liver-stage and gametocytes | ChAd63 | Phase IIb | (30, 54, 55) |
| Liver stage antigen 1 | LSA1 | 1,162 | PF3D7_1036400 | Liver-stage | ChAd63 and MVA | Pre-clinical | (29, 51, 54, 56) |
| Liver stage antigen 3 | LSA3 | 1,558 | PF3D7_0220000 | Liver-stage and blood stage | ChAd63 and MVA | Pre-clinical | (51) |
| Liver stage associated protein 1 | LSAP1 | 106 | PF3D7_1201300 | Sporozoite and liver-stage | ChAd63 and MVA | Pre-clinical | (51) |
| Liver stage associated protein 2 | LSAP2 | 302 | PF3D7_0202100 | Sporozoites, liver-stage and early ring stage | ChAd63 and MVA | Pre-clinical | (51) |
| Early transcribed membrane protein 5 | ETRAMP5 | 181 | PF3D7_0532100 | Sporozoite, liver-stage, blood-stage | ChAd63 and MVA | Pre-clinical | (51) |
| Cell traversal protein for ookinetes and sporozoites | CelTOS | 182 | PF3D7_1216600 | Sporozoite, liver-stage and gametocytes | ChAd63 and MVA | Pre-clinical | (51, 57) |
| Protein UIS3 | UIS3 | 229 | PF3D7_1302200 | Sporozoite, liver-stage and blood-stage | ChAd63 and MVA | Pre-clinical | (51) |
| Falstatin | Falstatin | 413 | PF3D7_0911900 | Sporozoite, liver-stage and blood-stage | ChAd63 and MVA | Pre-clinical | (51) |
| Liver specific protein 1 | LISP1 | 3,597 | PF3D7_1418100 | Liver stage | DNA | Pre-clinical | (43, 44) |
| Sporozoite and liver stage asparagine-rich protein | SLARP | 2,940 | PF3D7_1147000 | Liver stage | DNA | Pre-clinical | (43, 44) |
P. falciparum clone 3D7 accession numbers obtained from PlasmoDB Release 38 (58).